Patents by Inventor Gregory BLUEMLING

Gregory BLUEMLING has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ALKYNE CONTAINING NUCLEOTIDE AND NUCLEOSIDE THERAPEUTIC COMPOSITIONS AND USES RELATED THERETO
    Publication number: 20230062181
    Abstract: This disclosure relates to nucleotide and nucleoside therapeutic compounds and uses in treating infectious diseases viral infections, and cancer, where the base of the nucleotide or nucleoside contains at least one thiol, thione or thioether.
    Type: Application
    Filed: October 5, 2021
    Publication date: March 2, 2023
    Inventors: Gregory Bluemling, Abel de la Rosa, George Painter, Damien Kuiper, Alexander Kolykhalov
  • Alkyne containing nucleotide and nucleoside therapeutic compositions and uses related thereto
    Patent number: 11192914
    Abstract: This disclosure relates to nucleotide and nucleoside therapeutic compositions and uses in treating infectious diseases, viral infections, and cancer, where the nucleotide or nucleoside is defined by Formula I below,
    Type: Grant
    Filed: April 28, 2017
    Date of Patent: December 7, 2021
    Assignee: Emory University
    Inventors: Gregory Bluemling, Abel De La Rosa, George Painter, Damien Kuiper, Alexander Kolykhalov
  • ALKYNE CONTAINING NUCLEOTIDE AND NUCLEOSIDE THERAPEUTIC COMPOSITIONS AND USES RELATED THERETO
    Publication number: 20190144484
    Abstract: This disclosure relates to nucleotide and nucleoside therapeutic compositions and uses in treating infectious diseases, viral infections, and cancer, where the base of the nucleotide or nucleoside contains at least one thiol, thione or thioether.
    Type: Application
    Filed: April 28, 2017
    Publication date: May 16, 2019
    Inventors: Gregory BLUEMLING, Abel DE LA ROSA, George PAINTER, Damien KUIPER, Alexander KOLYKHALOV